Κ. Schöffling

2.0k total citations
133 papers, 866 citations indexed

About

Κ. Schöffling is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Κ. Schöffling has authored 133 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Surgery and 23 papers in Molecular Biology. Recurrent topics in Κ. Schöffling's work include Diabetes Management and Research (18 papers), Diabetes Treatment and Management (17 papers) and Hormonal Regulation and Hypertension (13 papers). Κ. Schöffling is often cited by papers focused on Diabetes Management and Research (18 papers), Diabetes Treatment and Management (17 papers) and Hormonal Regulation and Hypertension (13 papers). Κ. Schöffling collaborates with scholars based in Germany and United States. Κ. Schöffling's co-authors include E. F. Pfeiffer, K. Federlin, H. Ditschuneit, E Jungmann, P.-H. Althoff, U. Schwedes, E. Schifferdecker, C. Rosak, Thomas Nickélsen and H. Steigerwald and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Cancer.

In The Last Decade

Κ. Schöffling

120 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Κ. Schöffling Germany 16 440 181 151 132 97 133 866
José Rodrı́guez-Espinosa Spain 18 512 1.2× 299 1.7× 114 0.8× 150 1.1× 89 0.9× 55 1.2k
H. L. Krüskemper Germany 18 676 1.5× 70 0.4× 96 0.6× 164 1.2× 185 1.9× 86 1.1k
C. L. Cope United Kingdom 17 525 1.2× 181 1.0× 76 0.5× 116 0.9× 41 0.4× 39 1.2k
Fulya Akın Türkiye 18 543 1.2× 97 0.5× 77 0.5× 140 1.1× 85 0.9× 53 978
T. Russell Fraser United Kingdom 18 637 1.4× 166 0.9× 96 0.6× 229 1.7× 78 0.8× 48 1.3k
Ray Edwards United Kingdom 18 380 0.9× 173 1.0× 263 1.7× 146 1.1× 52 0.5× 51 1.0k
A Racadot France 14 219 0.5× 127 0.7× 56 0.4× 111 0.8× 48 0.5× 74 617
John B. Josimovich United States 22 415 0.9× 129 0.7× 152 1.0× 168 1.3× 174 1.8× 50 1.4k
S. K. Cunningham Ireland 19 547 1.2× 103 0.6× 55 0.4× 142 1.1× 179 1.8× 36 969
Charles F. Cobb United States 17 283 0.6× 207 1.1× 36 0.2× 112 0.8× 150 1.5× 23 1.1k

Countries citing papers authored by Κ. Schöffling

Since Specialization
Citations

This map shows the geographic impact of Κ. Schöffling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Κ. Schöffling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Κ. Schöffling more than expected).

Fields of papers citing papers by Κ. Schöffling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Κ. Schöffling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Κ. Schöffling. The network helps show where Κ. Schöffling may publish in the future.

Co-authorship network of co-authors of Κ. Schöffling

This figure shows the co-authorship network connecting the top 25 collaborators of Κ. Schöffling. A scholar is included among the top collaborators of Κ. Schöffling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Κ. Schöffling. Κ. Schöffling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nickélsen, Thomas, et al.. (2009). The Dexamethasone Suppression Test and Long-Term Contraceptive Treatment: Measurement of ACTH or Salivary Cortisol Does Not Improve the Reliability of the Test. Experimental and Clinical Endocrinology & Diabetes. 94(6). 275–280. 30 indexed citations
2.
Schifferdecker, E., Steffen Hering, Bernhard Böhm, et al.. (2009). Thyroid Hormone Binding Inhibition in Critically ill Patients – Who is the Inhibitor?. Experimental and Clinical Endocrinology & Diabetes. 95(2). 267–270. 2 indexed citations
3.
Haak, T, E Jungmann, Κ. Schöffling, & K.-H. Usadel. (2009). Evidence for Pulsatile Secretion of Human Atrial Natriuretic Peptide in Healthy Subjects. Experimental and Clinical Endocrinology & Diabetes. 99(2). 108–109.
4.
Bachmann, W. E., et al.. (2008). Wirksamkeit der Kombinationsbehandlung mit Glibenclamid und Insulin bei Sulfonylharnstoff-Sekundärversagen: Kontrollierte multizentrische doppelblinde klinische Prüfung. DMW - Deutsche Medizinische Wochenschrift. 113(16). 631–636. 2 indexed citations
5.
Schöffling, Κ., et al.. (2008). Glibenclamid-Insulin-Kombinationsbehandlung beim Sekundärversagen der Sulfonylharnstoff-Therapie*. DMW - Deutsche Medizinische Wochenschrift. 107(42). 1581–1583. 2 indexed citations
6.
Jungmann, E, Thomas Nickélsen, Kjeld Schmidt, et al.. (1991). [Somatomedin C level and stimulation of growth hormone and adrenal cortex function by administration of releasing hormones and physical exertion in patients with obesity].. PubMed. 86(5). 237–40. 5 indexed citations
7.
8.
Nickélsen, Thomas, et al.. (1991). Circadian Patterns of Salivary Melatonin and Urinary 6-Sulfatoxy-Melatonin before and after A 9 Hour Time-Shift. Advances in experimental medicine and biology. 294. 493–496. 7 indexed citations
9.
Boehm, B. O., Burkhard Manfras, C. Rosak, Κ. Schöffling, & Massimo Trucco. (1991). Aspartic acid at position 57 of the HLA-DQβ chain is protective against future development of insulin-dependent (Type 1) diabetes mellitus. Journal of Molecular Medicine. 69(4). 146–150. 3 indexed citations
10.
Jungmann, E, et al.. (1991). [Long-term antihypertensive treatment in diabetes mellitus. Results with the calcium antagonist felodipine].. PubMed. 109(3). 53–6. 7 indexed citations
11.
Haak, T, et al.. (1990). [The effect of atrial natriuretic peptide on glucose tolerance and insulin level].. PubMed. 85(2). 61–4. 5 indexed citations
12.
13.
Zeuzem, Stefan, E Jungmann, Thomas Henne, & Κ. Schöffling. (1989). Assessment of D-Glucose Uptake in Isolated Human Adipocytes. Hormone and Metabolic Research. 21(3). 156–157. 1 indexed citations
14.
Jungmann, E, T Haak, W Fassbinder, et al.. (1988). Impaired renal responsiveness to human atrial natriuretic peptide (hANP) in normotensive patients with type 1 diabetes mellitus. Journal of Molecular Medicine. 66(12). 527–532. 8 indexed citations
15.
Boehm, Bernhard O., E. Schifferdecker, P. Kuehnl, & Κ. Schöffling. (1988). Linkage of HLA-DRβ specific restriction fragment length polymorphisms with Graves' disease. European Journal of Endocrinology. 119(2). 251–256. 9 indexed citations
16.
Jungmann, E, et al.. (1986). Human atrial natriuretic peptide (hANP) has no effect upon dopaminergic pathways: preliminary evidence in nude mice bearing heterotransplanted human CONN's adenoma tissue.. PubMed. 64 Suppl 6. 47–9. 1 indexed citations
17.
Schwedes, U., Heinz Faulstich, Henryk Dancygier, et al.. (1981). Beneficial effect of somatostatin in phalloidin-intoxicated rats. Research in Experimental Medicine. 178(2). 155–163. 8 indexed citations
18.
Schöffling, Κ., et al.. (1977). [Secondary failures in modern therapy of diabetes mellitus with blood glucose lowering sulfonamides (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 72(38). 1529–36. 17 indexed citations
19.
Cordes, U., et al.. (1973). [Longtime effect of blood sugar decreasing sulfonamides on glucose tolerance and insulin secretion in adult diabetic patients].. PubMed. 79. 1216–20. 1 indexed citations
20.
Usadel, K. H., et al.. (1972). NERVENFASERN IN DEN TUBULUSWÄNDEN DER HODEN VON KLINEFELTER-PATIENTEN. HISTOCHEMISCHE UND ELEKTRONENOPTISCHE BEFUNDE. European Journal of Endocrinology. 68(3_Suppl). S99–S99.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Rodrı́guez-Espinosa Breakdown of academic impact, for papers by H. L. Krüskemper Breakdown of academic impact, for papers by C. L. Cope Breakdown of academic impact, for papers by Fulya Akın Breakdown of academic impact, for papers by T. Russell Fraser Breakdown of academic impact, for papers by Ray Edwards Breakdown of academic impact, for papers by A Racadot Breakdown of academic impact, for papers by John B. Josimovich Breakdown of academic impact, for papers by S. K. Cunningham Breakdown of academic impact, for papers by Charles F. Cobb
Rankless by CCL
2026